aser therapy of sebaceous hyperplasy

Not Applicable

Recruiting

• Conditions: ?Sebaceous hyperplasy.; Disorders of skin appendages; L60-L75

• Registration Number: IRCT201702016403N7
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Clinically documented sebaceous hyperplasy
Exclusion criteria: Pregnancy, breast feeding and skin repair disorder

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement. Timepoint: The end of 2th week, 1th, 3th, 6th, 12th months. Method of measurement: clinical observation.

Secondary Outcome Measures

Name	Time	Method
Complication( Hnfection, recurrence, scar, hyperpigmentation). Timepoint: The end 2 week, 1th, 3th, 6th and 12th months. Method of measurement: Clinical observation.